Skip to main content

David J. Moliterno, MD

Feature
06/19/2008
About TENACITY TENACITY (Tirofiban Novel Dosing vs. Abciximab with Evaluation of Clopidogrel and Inhibition of Thrombin Study) is a multi-center, double-blind, randomized comparison of tirofiban (Aggrastat®, Guilford Pharmaceuticals) and...
About TENACITY TENACITY (Tirofiban Novel Dosing vs. Abciximab with Evaluation of Clopidogrel and Inhibition of Thrombin Study) is a multi-center, double-blind, randomized comparison of tirofiban (Aggrastat®, Guilford Pharmaceuticals) and...
About TENACITY TENACITY...
06/19/2008
Cath Lab Digest
Feature
08/01/2008
Among patients with acute myocardial infarction (AMI), the efficacy of treatments that decrease mortality by coronary reperfusion and control of arrhythmia is dependent on time and access to acute medical care. Coronary reperfusion requires...
Among patients with acute myocardial infarction (AMI), the efficacy of treatments that decrease mortality by coronary reperfusion and control of arrhythmia is dependent on time and access to acute medical care. Coronary reperfusion requires...
Among patients with acute...
08/01/2008
Journal of Invasive Cardiology